Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast
Objectives The present study aimed to develop and validate nomograms to predict the survival of patients with breast invasive micropapillary carcinoma (IMPC) to aid objective decision-making.Design Prognostic factors were identified using Cox proportional hazards regression analyses and used to cons...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-02-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/2/e065312.full |
| _version_ | 1797896270488010752 |
|---|---|
| author | Zhihui Zhang Jia-yuan Sun Yulin Huang Yixin Cheng Pengkun Zhang Ru Tang Feng Chi Zhenyu He |
| author_facet | Zhihui Zhang Jia-yuan Sun Yulin Huang Yixin Cheng Pengkun Zhang Ru Tang Feng Chi Zhenyu He |
| author_sort | Zhihui Zhang |
| collection | DOAJ |
| description | Objectives The present study aimed to develop and validate nomograms to predict the survival of patients with breast invasive micropapillary carcinoma (IMPC) to aid objective decision-making.Design Prognostic factors were identified using Cox proportional hazards regression analyses and used to construct nomograms to predict overall survival (OS) and breast cancer-specific survival (BCSS) at 3 and 5 years. Kaplan-Meier analysis, calibration curves, the area under the curve (AUC) and the concordance index (C-index) evaluated the nomograms’ performance. Decision curve analysis (DCA), integrated discrimination improvement (IDI) and net reclassification improvement (NRI) were used to compare the nomograms with the American Joint Committee on Cancer (AJCC) staging system.Setting Patient data were collected from the Surveillance, Epidemiology, and End Results (SEER) database. This database holds data related to the incidence of cancer acquired from 18 population-based cancer registries in the US.Participants We ruled out 1893 patients and allowed the incorporation of 1340 patients into the present study.Results The C-index of the AJCC8 stage was lower than that of the OS nomogram (0.670 vs 0.766) and the OS nomograms had higher AUCs than the AJCC8 stage (3 years: 0.839 vs 0.735, 5 years: 0.787 vs 0.658). On calibration plots, the predicted and actual outcomes agreed well, and DCA revealed that the nomograms had better clinical utility compared with the conventional prognosis tool. In the training cohort, the NRI for OS was 0.227, and for BCSS was 0.182, while the IDI for OS was 0.070, and for BCSS was 0.078 (both p<0.001), confirming its accuracy. The Kaplan-Meier curves for nomogram-based risk stratification showed significant differences (p<0.001).Conclusions The nomograms showed excellent discrimination and clinical utility to predict OS and BCSS at 3 and 5 years, and could identify high-risk patients, thus providing IMPC patients with personalised treatment strategies. |
| first_indexed | 2024-04-10T07:39:05Z |
| format | Article |
| id | doaj.art-9097dcf6fd1448fa84da6b2b94573250 |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-04-10T07:39:05Z |
| publishDate | 2023-02-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-9097dcf6fd1448fa84da6b2b945732502023-02-23T12:00:12ZengBMJ Publishing GroupBMJ Open2044-60552023-02-0113210.1136/bmjopen-2022-065312Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breastZhihui Zhang0Jia-yuan Sun1Yulin Huang2Yixin Cheng3Pengkun Zhang4Ru Tang5Feng Chi6Zhenyu He7Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaDepartment of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, ChinaObjectives The present study aimed to develop and validate nomograms to predict the survival of patients with breast invasive micropapillary carcinoma (IMPC) to aid objective decision-making.Design Prognostic factors were identified using Cox proportional hazards regression analyses and used to construct nomograms to predict overall survival (OS) and breast cancer-specific survival (BCSS) at 3 and 5 years. Kaplan-Meier analysis, calibration curves, the area under the curve (AUC) and the concordance index (C-index) evaluated the nomograms’ performance. Decision curve analysis (DCA), integrated discrimination improvement (IDI) and net reclassification improvement (NRI) were used to compare the nomograms with the American Joint Committee on Cancer (AJCC) staging system.Setting Patient data were collected from the Surveillance, Epidemiology, and End Results (SEER) database. This database holds data related to the incidence of cancer acquired from 18 population-based cancer registries in the US.Participants We ruled out 1893 patients and allowed the incorporation of 1340 patients into the present study.Results The C-index of the AJCC8 stage was lower than that of the OS nomogram (0.670 vs 0.766) and the OS nomograms had higher AUCs than the AJCC8 stage (3 years: 0.839 vs 0.735, 5 years: 0.787 vs 0.658). On calibration plots, the predicted and actual outcomes agreed well, and DCA revealed that the nomograms had better clinical utility compared with the conventional prognosis tool. In the training cohort, the NRI for OS was 0.227, and for BCSS was 0.182, while the IDI for OS was 0.070, and for BCSS was 0.078 (both p<0.001), confirming its accuracy. The Kaplan-Meier curves for nomogram-based risk stratification showed significant differences (p<0.001).Conclusions The nomograms showed excellent discrimination and clinical utility to predict OS and BCSS at 3 and 5 years, and could identify high-risk patients, thus providing IMPC patients with personalised treatment strategies.https://bmjopen.bmj.com/content/13/2/e065312.full |
| spellingShingle | Zhihui Zhang Jia-yuan Sun Yulin Huang Yixin Cheng Pengkun Zhang Ru Tang Feng Chi Zhenyu He Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast BMJ Open |
| title | Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast |
| title_full | Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast |
| title_fullStr | Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast |
| title_full_unstemmed | Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast |
| title_short | Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast |
| title_sort | development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast |
| url | https://bmjopen.bmj.com/content/13/2/e065312.full |
| work_keys_str_mv | AT zhihuizhang developmentandvalidationofnomogramstopredictsurvivalinpatientswithinvasivemicropapillarycarcinomaofthebreast AT jiayuansun developmentandvalidationofnomogramstopredictsurvivalinpatientswithinvasivemicropapillarycarcinomaofthebreast AT yulinhuang developmentandvalidationofnomogramstopredictsurvivalinpatientswithinvasivemicropapillarycarcinomaofthebreast AT yixincheng developmentandvalidationofnomogramstopredictsurvivalinpatientswithinvasivemicropapillarycarcinomaofthebreast AT pengkunzhang developmentandvalidationofnomogramstopredictsurvivalinpatientswithinvasivemicropapillarycarcinomaofthebreast AT rutang developmentandvalidationofnomogramstopredictsurvivalinpatientswithinvasivemicropapillarycarcinomaofthebreast AT fengchi developmentandvalidationofnomogramstopredictsurvivalinpatientswithinvasivemicropapillarycarcinomaofthebreast AT zhenyuhe developmentandvalidationofnomogramstopredictsurvivalinpatientswithinvasivemicropapillarycarcinomaofthebreast |